Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Meilu Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates large-scale production facilities that comply with GMP standards, focusing on therapeutic areas such as cardiovascular health, anti-infectives, and digestive system disorders. Meilu Pharmaceutical provides a range of generic medications including tablets, capsules, and injections to the domestic and international markets. Additionally, the company offers contract manufacturing services (CMO) for global partners. It is recognized for its commitment to the Consistency Evaluation of generic drugs, ensuring high quality and bioequivalence to brand-name products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meilu Pharmaceutical.